APA (7th ed.) Citation

Mariani, J. J., Basaraba, C., Pavlicova, M., Alschuler, D. M., Brooks, D. J., Mahony, A. L., . . . Levin, F. R. (2023). Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder. American Journal of Drug & Alcohol Abuse, 49(5), 618. https://doi.org/10.1080/00952990.2023.2241981

Chicago Style (17th ed.) Citation

Mariani, John J., Cale Basaraba, Martina Pavlicova, Daniel M. Alschuler, Daniel J. Brooks, Amy L. Mahony, Christina Brezing, Nasir H. Naqvi, and Frances R. Levin. "Open Label Trial of Lofexidine-assisted Non-opioid Induction onto Naltrexone Extended-release Injection for Opioid Use Disorder." American Journal of Drug & Alcohol Abuse 49, no. 5 (2023): 618. https://doi.org/10.1080/00952990.2023.2241981.

MLA (9th ed.) Citation

Mariani, John J., et al. "Open Label Trial of Lofexidine-assisted Non-opioid Induction onto Naltrexone Extended-release Injection for Opioid Use Disorder." American Journal of Drug & Alcohol Abuse, vol. 49, no. 5, 2023, p. 618, https://doi.org/10.1080/00952990.2023.2241981.